Navigation Links
Isolagen Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under Chapter 11 of the United States Bankruptcy Code
Date:5/6/2009

additional information, please visit www.isolagen.com.

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release, include, without limitation, the Company's ability to obtain debtor-in-possession financing, the date on which the Company's common stock will be delisted from the NYSE Amex, if any, and the date on which the Company's common stock is quoted on the OTC Bulletin Board if the common stock is delisted from the NYSE Amex. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of our control, that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, as updated in "Item 1A. Risk Factors" in the Company's Quarterly Reports on Form 10-Q filed since the annual report. We operate in a highly competitive and rapidly changing environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise any
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
2. Isolagen, Inc. Reports Receipt of Initiation of Delisting Proceedings Notice from Amex
3. Isolagen, Inc. Sells Switzerland Facility
4. Isolagen, Inc. Promotes Todd Greenspan to Chief Financial Officer (CFO)
5. Isolagen, Inc. Receives Notification Letter from American Stock Exchange
6. Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
7. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
8. Isolagen Modifies Ongoing Clinical Program for Acne Scars
9. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
10. Isolagen, Inc. Postpones Annual Meeting
11. Bertram Receives Organizational Innovation Award at AONE Conference -- Award Sponsor B. E. Smith Also Announces Funding for Three Seed Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Steven Reinberg HealthDay Reporter ... uncovered a key factor to explain why antibiotic-resistant bacteria can ... DNA called plasmids appear to be the culprit. They can ... and some carry a gene that makes bacteria drug-resistant, a ... carry an antibiotic-resistant gene to a class of antibiotic called ...
(Date:9/17/2014)... able to reduce the need for invasive biopsies in ... lupus. , In a new study, researchers developed a ... kidney inflammation to interstitial fibrosis, scarring in ... biopsy is the only existing way to reach a ... The model could also be used to monitor the ...
(Date:9/17/2014)... September 17, 2014 Today, Blue ... million in third-quarter grantmaking. This body of grants aims ... spreading innovations in care delivery, as well as to ... uninsured. Grants will also strengthen the capacity of both ... responsive and create new entry points for domestic violence ...
(Date:9/17/2014)... 2014 In a country where 77% ... a regular basis, how can Americans find healthy and ... Hyland’s Stress Challenge , a 5-day interactive journey to ... life. From September 29th – October 3rd, the ... relating to specific topics that promote natural solutions for ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... confirmed cases of Enterovirus D68, the severe respiratory illnesses ... officials report. Alabama, Colorado, Illinois, Indiana, Iowa, Kansas, ... have 130 laboratory-confirmed cases of Enterovirus D68, according to ... The virus, part of the family of viruses that ...
Breaking Medicine News(10 mins):Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Math model designed to replace invasive kidney biopsy for lupus patients 2Health News:Blue Shield of California Foundation Awards $5 Million in Third-Quarter Grants 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 3
... , WEDNESDAY, Feb. 9 (HealthDay News) -- The number ... attempts swings sharply depending on what month it is, a ... for men aged 50 and older, while there was little ... the report from the Substance Abuse and Mental Health Services ...
... many patients realise that diabetes can affect their kidneys is ... multi-cultural study in the March issue of the Journal ... to 48 patients with diabetes attending specialist renal services in ... risks posed by the disease was very low. ...
... Researchers from the Hospital Virgen de las Nieves of ... frequent mutations in the gene KCNH2 in patients with long ... cardiac ionic channels that approximately affects one in every 2,500 ... trigger sudden death. This condition usually affects children and adolescents, ...
... Sciences Discovery Fund (LSDF) today announced nearly $600,000 in ... the diagnosis and management of major health conditions. ... producing novel tests to diagnose or monitor disease. Jane ... a Washington-based company, will adapt a novel air sampling ...
... HealthDay Reporter , TUESDAY, Feb. 8 (HealthDay News) -- Men ... bearing children with congenital problems such as a cleft palate compared ... research. But the overall risk was low, researchers from Sweden ... of the National Cancer Institute . And the findings ...
... at the University at Buffalo have devised two new ... important molecules from losing their shape and degrading in ... the development of peptide-based drugs against diseases including cancer. ... than existing techniques, one of which employs an expensive ...
Cached Medicine News:Health News:Males' Drug-Related Suicide Attempts Vary by Month 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 3Health News:Researchers identify the genotype of disorders causing cardiac sudden death syndrome 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 3Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 2Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 3Health News:New techniques for stapling peptides could spur development of drugs for cancer 2
(Date:9/17/2014)... Sept. 17, 2014 Bronstein, Gewirtz & Grossman, ... of the securities of PDL BioPharma, Inc. ("PDL BioPharma" ... Such investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. ... of its executives violated federal securities laws. ...
(Date:9/17/2014)... September 17, 2014 ... has shown positive data in a Phase 2a proof ... , Glenmark Pharmaceuticals today announced ... 1 (TRPA1) antagonist, GRC 17536 has shown positive data ... proof of concept study conducted on 138 patients in ...
(Date:9/17/2014)... 2014   MedeAnalytics today unveils Revenue ... complete visibility to a provider,s "mid-cycle" to optimize ... landscape. Powered by the industry,s leading big data ... point between patient access and the business office ... improve revenue capture, minimize audit risk and prepare ...
Breaking Medicine Technology:Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... New study finds patients who opt for surgery have decreased pain, ... with the spine disease called degenerative spondylolisthesis * ... pain over time compared to those who do not have surgery, ... The Journal of Bone and Joint Surgery ...
... GAITHERSBURG, Md., June 1 Overall survival data in ... GenVec,s ongoing Phase III Pancreatic Cancer Clinical Trial with ... Society of Clinical Oncology Annual Meeting in Orlando, FL. ... ) , , The poster ...
Cached Medicine Technology:Back to Normal: Surgery Improves Outcomes for Spine Patients 2Back to Normal: Surgery Improves Outcomes for Spine Patients 3Back to Normal: Surgery Improves Outcomes for Spine Patients 4TNFerade(TM) Phase III Data Presented at ASCO 2TNFerade(TM) Phase III Data Presented at ASCO 3
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
... Radical can operate in two additional ... be removed, creating a fully featured handheld ... also be used to upgrade existing equipment ... additinal hardware or software upgrades to improve ...
Halogen-free immersion oil based on ester oil....
Immersion Oil, 150 cs...
Medicine Products: